Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
Between the Biotech Waves
00:00
Is Volume Driven Investing a Good Thing?
Are you actually starting to see this requisite sort of trading that's not taking place around a stock? And is that actual volume driven as investors are selling and buying? Or is it some other metric? Yeah, I think it's yet to be determined. We do see companies that have more extended runways than those who have kept their cash position between 18 to 24 months or greater performing better.
Transcript
Play full episode
